Kelly McKee

Kelly McKee serves as vice president of Decentralized Clinical Trials (DCTs) and Patient Registries at Medidata. She is responsible for creating new solutions to engage patients pre-trial, in-trial, and post-trial, to improve access, awareness, and inclusion of patients in clinical research. Kelly is a proven clinical trial leader and trailblazer in operationalizing global solutions across organizations including innovations in optimizing patient, site, and sponsor experiences. Prior to Medidata, she spent over 20 years within clinical operations and patient recruitment at top-tier pharmaceutical companies including Sanofi, Merck, Eli Lilly and Co., and Vertex Pharmaceuticals. Kelly is passionate about celebrating the role that clinical trial participants bring in making new medicines and vaccines possible and was named one of Life Sci Voice’s Top Industry Leaders in 2022, PharmaVoice’s 100 Most Inspiring Leaders in 2020, Centerwatch’s Top 20 Innovators of 2018, and PharmaTimes’ Clinical Researcher of the Year, Clinical Research Teams, in 2012. She holds a bachelor’s degree in biology from Bryn Mawr College and a masters degree in clinical research administration from George Washington University.